Literature DB >> 9219219

Vascular endothelial cadherin (VE-cadherin): cloning and role in endothelial cell-cell adhesion.

J Ali1, F Liao, E Martens, W A Muller.   

Abstract

OBJECTIVE: To identify proteins responsible for intercellular junction integrity in human umbilical vein endothelial cells (HUVEC), we produced a monoclonal antibody that recognized an endothelial cell-specific, junctionally restricted protein. We characterized and cloned the antigen to study its functional properties.
METHODS: The size and cellular distribution of the antigen were determined by immunofluorescence and immunoprecipitation. The molecule was cloned and transfected into cell lines, and its role in cell-cell adhesion and growth rate was determined.
RESULTS: Monoclonal antibody hec1 recognizes VE-cadherin, an endothelial cell-restricted cell adhesion molecule. VE-cadherin is localized to the borders between apposing endothelial cells but is diffusely distributed on subconfluent or migrating cells. Transfection of fibroblasts with VE-cadherin imparts to them the ability to adhere to each other in a calcium-dependent homophilic manner. Expression of VE-cadherin over a several-log range does not change the growth rate of these cells.
CONCLUSIONS: Despite the fact that VE-cadherin is a "nonclassical" cadherin by structure, it functions as a classic cadherin by imparting to cells the ability to adhere in a calcium-dependent, homophilic manner. On HUVEC it appears to play a role in maintaining monolayer integrity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9219219     DOI: 10.3109/10739689709146790

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  24 in total

1.  p120-Catenin prevents neutrophil transmigration independently of RhoA inhibition by impairing Src dependent VE-cadherin phosphorylation.

Authors:  Pilar Alcaide; Roberta Martinelli; Gail Newton; Marcie R Williams; Alejandro Adam; Peter A Vincent; Francis W Luscinskas
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-30       Impact factor: 4.249

2.  Conversion of cultured monocytes/macrophages into endothelial-like cells through direct contact with endothelial cells.

Authors:  Miyako Bohgaki; Hiromichi Kitaguchi
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

3.  Segregation of VE-cadherin from the LBRC depends on the ectodomain sequence required for homophilic adhesion.

Authors:  Gong Feng; David P Sullivan; Fei Han; William A Muller
Journal:  J Cell Sci       Date:  2015-02-01       Impact factor: 5.285

4.  Endothelial CD47 promotes vascular endothelial-cadherin tyrosine phosphorylation and participates in T cell recruitment at sites of inflammation in vivo.

Authors:  Veronica Azcutia; Michael Stefanidakis; Naotake Tsuboi; Tanya Mayadas; Kevin J Croce; Daiju Fukuda; Masanori Aikawa; Gail Newton; Francis W Luscinskas
Journal:  J Immunol       Date:  2012-07-18       Impact factor: 5.422

5.  How endothelial cells regulate transmigration of leukocytes in the inflammatory response.

Authors:  William A Muller
Journal:  Am J Pathol       Date:  2014-04       Impact factor: 4.307

6.  A discrete interface in matrix stiffness creates an oscillatory pattern of endothelial monolayer disruption.

Authors:  Jacob A VanderBurgh; Archit V Potharazu; Samantha C Schwager; Cynthia A Reinhart-King
Journal:  J Cell Sci       Date:  2020-09-17       Impact factor: 5.285

7.  Isolation of endothelial progenitor cells from cord blood and induction of differentiation by ex vivo expansion.

Authors:  Jeong-Won Shin; Dong-Wha Lee; Moon-Jung Kim; Kyung-Soon Song; Han-Soo Kim; Hyun-Ok Kim
Journal:  Yonsei Med J       Date:  2005-04-30       Impact factor: 2.759

8.  Poliovirus receptor (CD155) regulates a step in transendothelial migration between PECAM and CD99.

Authors:  David P Sullivan; Michael A Seidman; William A Muller
Journal:  Am J Pathol       Date:  2013-01-18       Impact factor: 4.307

9.  Claudin-5 controls intercellular barriers of human dermal microvascular but not human umbilical vein endothelial cells.

Authors:  Martin S Kluger; Paul R Clark; George Tellides; Volker Gerke; Jordan S Pober
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

10.  Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease.

Authors:  Ryan C Winger; Christopher T Harp; Ming-Yi Chiang; David P Sullivan; Richard L Watson; Evan W Weber; Joseph R Podojil; Stephen D Miller; William A Muller
Journal:  J Immunol       Date:  2016-01-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.